Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy
NCT03702140
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
"Teriparatide", "Forteo® or Teribon"
Sponsor
Shinshu University